{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:18:46Z","timestamp":1770434326637,"version":"3.49.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.vaccine.2007.10.056","type":"journal-article","created":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T16:58:29Z","timestamp":1196873909000},"page":"128-139","source":"Crossref","is-referenced-by-count":72,"title":["Cost-effectiveness of quadrivalent human papillomavirus (HPV) vaccination in Mexico: A transmission dynamic model-based evaluation"],"prefix":"10.1016","volume":"26","author":[{"given":"Ralph P.","family":"Insinga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik J.","family":"Dasbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elamin H.","family":"Elbasha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Puig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luz Myriam","family":"Reynales-Shigematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2007.10.056_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.vaccine.2007.10.056_bib2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0188-0128(99)00006-8","article-title":"Cervical cancer screening in developing countries: why is it ineffective? The case of Mexico","volume":"30","author":"Lazcano-Ponce","year":"1999","journal-title":"Arch Med Res"},{"key":"10.1016\/j.vaccine.2007.10.056_bib3","unstructured":"Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancerbase No. 5 version 2.0, IARC Press, Lyon, 2004."},{"key":"10.1016\/j.vaccine.2007.10.056_bib4","unstructured":"Distribuci\u00f3n de defunciones por c\u00e1ncer c\u00e9rvico uterino seg\u00fan entidad federativa de residencia habitual de la mujer y grupos de edad, 2004. Direcci\u00f3n General Adjunta de Salud Reproductiva, INEGI\/Ssa, Aguascalientes, Mexico, 2004."},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.056_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.056_bib6","first-page":"1934","article-title":"Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites","volume":"61","author":"Carter","year":"2001","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.vaccine.2007.10.056_bib7","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1128\/JCM.37.10.3316-3322.1999","article-title":"Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients","volume":"37","author":"Brown","year":"1999","journal-title":"J Clin Microbiol"},{"issue":"10 Pt 1","key":"10.1016\/j.vaccine.2007.10.056_bib8","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/000348949510401002","article-title":"Adult respiratory papillomatosis: human papillomavirus type and viral coinfections as predictors of prognosis","volume":"104","author":"Pou","year":"1995","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.10.056_bib9","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/00005537-199707000-00015","article-title":"Pediatric respiratory papillomatosis: prognostic role of viral typing and cofactors","volume":"107","author":"Rimell","year":"1997","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.056_bib10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","article-title":"Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review","volume":"14","author":"Kreimer","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.056_bib11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1086\/505982","article-title":"Genital human papillomavirus infection","volume":"43","author":"Dunne","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.056_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3201\/eid1301.060438","article-title":"Model for assessing human papillomavirus vaccination strategies","volume":"13","author":"Elbasha","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2007.10.056_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/epirev\/mxj006","article-title":"Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease","volume":"28","author":"Dasbach","year":"2006","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.vaccine.2007.10.056_bib14","unstructured":"Proyecciones de la poblaci\u00f3n de M\u00e9xico, 2000\u20132050. Consejo Nacional de Poblaci\u00f3n. M\u00e9xico, DF: CONAPO, 2002."},{"key":"10.1016\/j.vaccine.2007.10.056_bib15","series-title":"The social organization of sexuality","author":"Laumann","year":"1994"},{"key":"10.1016\/j.vaccine.2007.10.056_bib16","unstructured":"Primera encuesta nacional sobre sexo: estudio de opinion en viviendas. 2004. Consulta Mitofsky, Aguascalientes, Mexico. http:\/\/www.consulta.com.mx; Accessed: August 2006."},{"issue":"6","key":"10.1016\/j.vaccine.2007.10.056_bib17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00001648-200211000-00006","article-title":"The theoretical population-level impact of a prophylactic human papilloma virus vaccine","volume":"13","author":"Hughes","year":"2002","journal-title":"Epidemiology"},{"key":"10.1016\/j.vaccine.2007.10.056_bib18","unstructured":"Insinga RP, Dasbach EJ, Elbasha EH. Epidemiologic natural history and clinical management of human papillomavirus (HPV) disease: A critical review of the literature in the development of an HPV dynamic transmission model; 2006. Under review."},{"issue":"4","key":"10.1016\/j.vaccine.2007.10.056_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000326174","article-title":"Natural history of cervical intraepithelial neoplasia: a meta-analysis","volume":"49","author":"Cantor","year":"2005","journal-title":"Acta Cytol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.10.056_bib20","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ijc.11334","article-title":"A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16\/18 vaccine","volume":"106","author":"Goldie","year":"2003","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.vaccine.2007.10.056_bib21","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/oxfordjournals.aje.a010166","article-title":"Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis","volume":"151","author":"Myers","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.056_bib22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","article-title":"Natural history of cervical intraepithelial neoplasia: a critical review","volume":"12","author":"Ostor","year":"1993","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.vaccine.2007.10.056_bib23","unstructured":"Louftalot M. Avances del programa de detecci\u00f3n oportuna del c\u00e1ncer cervical en M\u00e9xico. 3-3-2005. Presented at the XI Congreso de Investigaci\u00f3n en Salud P\u00fablica, Cuernavaca, Mexico: also available at: http:\/\/www.insp.mx\/2005\/xicongreso\/ponencias\/as\/j\/1.ppt."},{"key":"10.1016\/j.vaccine.2007.10.056_bib24","unstructured":"Unpublished data. Instituto Mexicano de Seguridad Social, D.F., Mexico, 2004."},{"key":"10.1016\/j.vaccine.2007.10.056_bib25","unstructured":"Encuesta Nacional de Salud Reproductiva 2003: Principales Resultados. Secretaria de Salud, D.F., Mexico, 2003, www.letraese.org.mx\/sxencuestasaludreproductiva.ppt."},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.056_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0020-7292(01)00471-4","article-title":"Prognostic factors related to cervical cancer survival in Mexican women","volume":"75","author":"Flores-Luna","year":"2001","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.056_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0028-2243(94)01970-I","article-title":"Cervical cancer screening with cervicography and cytology","volume":"58","author":"Baldauf","year":"1995","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.056_bib28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.bjc.6602728","article-title":"The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women","volume":"93","author":"Bigras","year":"2005","journal-title":"Br J Cancer"},{"issue":"7392","key":"10.1016\/j.vaccine.2007.10.056_bib29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/bmj.326.7392.733","article-title":"Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening","volume":"326","author":"Coste","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.056_bib30","first-page":"53","article-title":"A comparison of simultaneous cervical cytology, HPV testing, and colposcopy","volume":"12","author":"Hockstad","year":"1992","journal-title":"Fam Pract Res J"},{"issue":"3","key":"10.1016\/j.vaccine.2007.10.056_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0020-7292(93)90518-2","article-title":"Papanicolaou smear screening augmented by a magnified chemiluminescent exam","volume":"43","author":"Mann","year":"1993","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"10.1016\/j.vaccine.2007.10.056_bib32","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0029-7844(98)00006-4","article-title":"Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis","volume":"91","author":"Mitchell","year":"1998","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.10.056_bib33","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1471-0528.1997.tb11983.x","article-title":"A study of treatment failures following large loop excision of the transformation zone for the treatment of cervical intraepithelial neoplasia","volume":"104","author":"Flannelly","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.056_bib34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1471-0528.2002.01554.x","article-title":"Persistent infection with human papillomavirus following the successful treatment of high grade cervical intraepithelial neoplasia","volume":"109","author":"Cruickshank","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.vaccine.2007.10.056_bib35","unstructured":"SEER*Stat 6.3.5 \u2013 SEER Cancer Incidence Limited-Use Database, 1973\u20132004 and Associated Populations in Binary Format for Use by SEER*Stat. 4-16-2007. Bethesda, MD, U.S.A., Cancer Statistics Branch, National Cancer Institute, National Insititutes of Health."},{"key":"10.1016\/j.vaccine.2007.10.056_bib36","unstructured":"Avances del programa de deteccion oportuna del cancer cervical en Mexico. Direccion de Prevencion y Control del Cancer en la Mujer, Centro de Equidad de Genero y Salud Reproductiva, Secretaria de Salud, D.F., Mexico, March 2005."},{"issue":"21","key":"10.1016\/j.vaccine.2007.10.056_bib37","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","article-title":"A controlled trial of a human papillomavirus type 16 vaccine","volume":"347","author":"Koutsky","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2007.10.056_bib38","unstructured":"Gardasil Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine. 4-4-2007. Product Approval Information, U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Rockville, MD."},{"issue":"11","key":"10.1016\/j.vaccine.2007.10.056_bib39","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","article-title":"High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6\/11\/16\/18 L1 virus-like particle vaccine through 5 years of follow-up","volume":"95","author":"Villa","year":"2006","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.vaccine.2007.10.056_bib40","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/jnci\/djh104","article-title":"Projected clinical benefits and cost-effectiveness of a human papillomavirus 16\/18 vaccine","volume":"96","author":"Goldie","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.056_bib41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3201\/eid0901.020168","article-title":"Cost-effectiveness of a potential vaccine for human papillomavirus","volume":"9","author":"Sanders","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2007.10.056_bib42","series-title":"Vaccines for the 21st century: a tool for decision making","year":"1999"},{"issue":"11","key":"10.1016\/j.vaccine.2007.10.056_bib43","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/375074","article-title":"The health and economic burden of genital warts in a set of private health plans in the United States","volume":"36","author":"Insinga","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.056_bib44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ajog.2004.01.042","article-title":"The health care costs of cervical human papillomavirus-related disease","volume":"191","author":"Insinga","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2007.10.056_bib45","unstructured":"Treasury Reporting Rates of Exchange. Financial Management Service: A bureau of the United States Treasury http:\/\/www.fms.treas.gov\/intn.html#rates. Accessed: January 3, 2007."},{"key":"10.1016\/j.vaccine.2007.10.056_bib46","unstructured":"Inflacion. Banco de Mexico http:\/\/www.banxico.org.mx\/PortalesEspecializados\/inflacion\/inflacion.html. Accessed: August 2, 2006."},{"key":"10.1016\/j.vaccine.2007.10.056_bib47","unstructured":"Elbasha EH, Dasbach EJ, Insinga RP. A multi-type HPV transmission model assessing the economic impact of a quadrivalent HPV vaccine. 2006. Under review."},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.056_bib48","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","article-title":"Against which human papillomavirus types shall we vaccinate and screen? The international perspective","volume":"111","author":"Munoz","year":"2004","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.vaccine.2007.10.056_bib49","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1258\/0956462981921143","article-title":"An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle","volume":"9","author":"Maw","year":"1998","journal-title":"Int J STD AIDS"},{"issue":"4","key":"10.1016\/j.vaccine.2007.10.056_bib50","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archderm.1984.01650400051012","article-title":"Condyloma acuminatum in Rochester, Minn., 1950\u20131978. I. Epidemiology and clinical features","volume":"120","author":"Chuang","year":"1984","journal-title":"Arch Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2007.10.056_bib51","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1086\/342109","article-title":"External genital warts: diagnosis, treatment, and prevention","volume":"35","author":"Wiley","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2007.10.056_bib52","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1590\/S0034-89101998000600009","article-title":"Cost-effectiveness of interventions for end-stage renal disease","volume":"32","author":"Arredondo","year":"1998","journal-title":"Rev Saude Publica"},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.056_bib53","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.arcmed.2005.11.010","article-title":"Cost-effectiveness of chronic hepatitis C treatment with thymosin alpha-1","volume":"37","author":"Garcia-Contreras","year":"2006","journal-title":"Arch Med Res"},{"issue":"9547","key":"10.1016\/j.vaccine.2007.10.056_bib54","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(06)69567-6","article-title":"Priority setting for health interventions in Mexico's System of Social Protection in Health","volume":"368","author":"Gonzalez-Pier","year":"2006","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2007.10.056_bib55","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1377\/hlthaff.24.3.666","article-title":"Overcoming economic barriers to the optimal use of vaccines","volume":"24","author":"Lieu","year":"2005","journal-title":"Health Aff (Millwood)"},{"issue":"7","key":"10.1016\/j.vaccine.2007.10.056_bib56","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1371\/journal.pmed.0030241","article-title":"Cost-effectiveness of treating multidrug-resistant tuberculosis","volume":"3","author":"Resch","year":"2006","journal-title":"Plos Med"},{"key":"10.1016\/j.vaccine.2007.10.056_bib57","unstructured":"The world factbook: Mexico. United States Central Intelligence Agency: https:\/\/cia.gov\/cia\/\/publications\/factbook\/geos\/mx.html#Econ. Accessed: December 6, 2006."},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.056_bib58","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.whi.2006.06.005","article-title":"Annual productivity costs due to cervical cancer mortality in the United States","volume":"16","author":"Insinga","year":"2006","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.vaccine.2007.10.056_bib59","series-title":"Cost-effectiveness in health and medicine","year":"1996"},{"key":"10.1016\/j.vaccine.2007.10.056_bib60","unstructured":"Guidelines for the economic evaluation of health technologies: Canada. 3rd ed. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2006."},{"issue":"9518","key":"10.1016\/j.vaccine.2007.10.056_bib61","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2007.10.056_bib62","first-page":"279","article-title":"Costs and quality of the timely detection of cervix uteri cancer at a public clinica and at a non-government organization","volume":"43","author":"Gomez-Jauregui","year":"2001","journal-title":"Salud Publica Mex"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2007.10.056_bib63","doi-asserted-by":"crossref","first-page":"S315","DOI":"10.1590\/S0036-36342003000900005","article-title":"Cervical cancer, a disease of poverty: mortality differences between urban and rural areas in Mexico","volume":"45","author":"Palacio-Mejia","year":"2003","journal-title":"Salud Publica Mex"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07012261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07012261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T04:44:25Z","timestamp":1588135465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07012261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0264410X07012261"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.056","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}